Clinical trials for ALK-positive large B-cell lymphoma
3 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 2NCT06550141Emapalumab Prevention of CAR-T Cell Associated ToxicitiesMarcela V. Maus, M.D.,Ph.D. · PI: Matthew Frigault, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05507541TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaMayo Clinic · PI: Stephen M. Ansell, MD, PhD
- RECRUITINGPhase 1NCT05544019Study of SGR-1505 in Mature B-Cell NeoplasmsSchrödinger, Inc. · PI: Frank G Basile, M.D.